Celebrating the First Clinical Administration of Elucirem™ (Gadopiclenol) Injection for MRI

Guerbet Showcases MR Agent Elucirem™ (Gadopiclenol) injection, Administered at Half the Dose of Gadolinium, and AI Suite

Bracco’s Commitment to Advancing the Future of Imaging Has No Boundaries

Researchers Develop Single-Chain Nanoparticles That Could Serve as Contrast Agents

PROMISE Reinforces Safety, Efficacy of Gadopiclenol MRI Contrast

Copper in MRI Contrast Agents Could Create Clearer Images

Guerbet and Applied Radiology Launch Elucirem | The Reveal Image Challenge

ACR Classifies Bracco's VUEWAY as Group II Agent

ACR Committee Classifies Guerbet’s Elucirem a Group II Agent

GE HealthCare Launches New MRI Agent

First Patient Dosed With Newly Commercialized Elucirem MRI Contrast

MRI Contrast Innovation | A New High-Relaxivity, High Stability GBCA

Normative Left Ventricular Segmental T2 Mapping Values and Relationship With Cardiac Function in Cardiac Sarcoidosis Patients

By Chamberlin J, Kabakus IM, Kocher MR, Aquino G, Waltz J, Stringer N, Dennis DJ, Wortham A, Varga-Szemes A, Reiter W, James WE, Houston BA, Baruah D, Hardie AD, Burt JR

Guerbet Prepares for Launch of Elucirem (Gadopiclenol) injection, High-Relaxivity MRI Contrast Agent

The Promise of VUEWAY™ Gadopiclenol Injection

Neurological MRI: Trends in Contrast Utilization

Radiologists Concerned With Contrast Agent Availability as MRI Procedures Increase

Gadoxetate Disodium MRI Identifies Hepatocellular Adenomas

Fresenius Kabi Launches New Brain MRI Contrast

FDA Approves Bracco Diagnostics’ Gadopiclenol Injection, VUEWAY

US FDA Approves Guerbet’s Elucirem MRI Contrast

Contrast-Enhanced In-Phase Dixon Sequence for Detecting Breast Biopsy Clips

MR Contrast Produced by Adding Gadolinium Ions to Calcium Carbonate Prenucleation Clusters

The Use of Contrast-enhanced MRI in At-risk Patient Populations

By Tanenbaum LN, Roberts D

MRI Contrast Selection: Greater Stability or Higher Relaxivity?

Diffuse Leptomeningeal Glioneural Tumor

Clinical Trial of Gadolinium-Free MRI Contrast Starts

Langerhans Cell Histiocytosis | Case 2

FDA Recommends Thyroid Monitoring in Babies and Young Children Who Receive Iodine-Containing Contrast Media

FDA, EMA to Review Gadopiclenol

Reaction to CT Contrast Increases MRI Contrast Risk

Small Coil MRI of the Nipple-Areola Complex and Retroareolar Breast

By Muñoz MS, Alvares ML, Tisera DM, Muñoz ME

The Future of Magnetic Resonance Imaging Contrast Agents

By Minton LE, Pandit R, Willoughby WR, Porter KK

Enhancing MR Suite Efficiency During the Pandemic

AI Takes Neuro MRI to the Next Level of Care

Guerbet, Bracco to Collaborate on Next Generation MRI Contrast

Contrast-enhanced MRI: History and Current Recommendations

By Minton LE, Pandit R, Porter KK

Cardiac MRI of Myocarditis in Adolescents after COVID-19 Vaccine

New Scientific Advisory Board Will Guide Voyageur Pharmaceuticals

Molecular breast imaging found useful as adjunct to mammography